a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.
Ticker / NAME | Correlation To ETNB | 1D Price Change % | ||
---|---|---|---|---|
ETNB | 100% | -3.82% | ||
AKRO - ETNB | 64% Loosely correlated | -3.11% | ||
EDIT - ETNB | 49% Loosely correlated | -2.43% | ||
PLRX - ETNB | 48% Loosely correlated | -2.87% | ||
NTLA - ETNB | 47% Loosely correlated | -5.41% | ||
MDGL - ETNB | 46% Loosely correlated | -0.55% | ||
More |